5FLC
Architecture of human mTOR Complex 1 - 5.9 Angstrom reconstruction
Summary for 5FLC
Entry DOI | 10.2210/pdb5flc/pdb |
EMDB information | 3213 |
Descriptor | SERINE/THREONINE-PROTEIN KINASE MTOR, REGULATORY-ASSOCIATED PROTEIN OF MTOR, FKBP, ... (7 entities in total) |
Functional Keywords | transferase, rapamycin, mtorc1 |
Biological source | HOMO SAPIENS (HUMAN) More |
Total number of polymer chains | 12 |
Total formula weight | 702027.97 |
Authors | Aylett, C.H.S.,Sauer, E.,Imseng, S.,Boehringer, D.,Hall, M.N.,Ban, N.,Maier, T. (deposition date: 2015-10-23, release date: 2015-12-30, Last modification date: 2024-05-08) |
Primary citation | Aylett, C.H.S.,Sauer, E.,Imseng, S.,Boehringer, D.,Hall, M.N.,Ban, N.,Maier, T. Architecture of Human Mtor Complex 1 Science, 351:48-, 2016 Cited by PubMed Abstract: Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site. PubMed: 26678875DOI: 10.1126/SCIENCE.AAA3870 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (5.9 Å) |
Structure validation
Download full validation report